MJTV Joint Venture Partner Genesis Botanical Signs Contract For 40 Acres Of Hemp Biomass For Its CBD Extraction Facility As Well As Further Expansion
- U.S. stocks close down on news of Biden tax proposal
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
- Snap (SNAP) Tops Q1 EPS by 5c, DAUs were 280 million, Offers Guidance
- Credit Suisse (CS) Falls 6% on 'Unacceptable Loss' as Exposure to Archegos Grew to More Than $20 Billion, Set to Raise Over $2 Billion to Support Liquidity
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
CHEYENNE, WY / ACCESSWIRE / February 1, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), is pleased to announce, its wholly-owned Subsidiary, New England Biotech's partner Genesis Botanical, signed its first contract with a Maine farmer to provide 40 acres of hemp biomass for extraction for the 2021 farming season.
Company executives met with the farmer and his team at their indoor facility to discuss and advise on the different varieties of hemp to be grown. The MJ Biotech's team and joint venture partners are making sure the highest profitability is reached. The goal of MJTV and the farmers is to maximize profitability through a pragmatic, experienced hands-on approach.
This is the first extraction contract secured. The Company is focused on securing the business necessary to be profitable within the first month or two of opening the first CBD Extraction Facility. More contracts will be secured shortly and the plans for a second facility will soon be in place.
The site of the first Facility, as announced, will be in Sagadahoc County in Mid-Coast Central Maine. The second facility, already under consideration, will expand operations along the East Coast of the United States.
For additional information please contact us at email@example.com
Safe Harbor Statement: Some of the statements in this press release may be forward-looking statements or statements of future expectations based on currently available information. Such statements are naturally subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. MJ Biotech Inc. does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated status of such statements. Therefore, in no case whatsoever will MJ Biotech. Inc. and its affiliate companies be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.
SOURCE: MJ Biotech, Inc.
View source version on accesswire.com:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hempstract Inc. Completes Financial Forecasts for Tolling Agreements.
- Colony Bankcorp Reports First Quarter 2021 Results
- SciPlay to Report First Quarter 2021 Results on Monday, May 10, 2021
Create E-mail Alert Related CategoriesAccesswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!